M&A

For biotech dealmakers, it’s everything, everywhere all at once
Fierce Biotech
Wed, 01/17/24 - 09:40 am
M&A
IPOs
reverse merger
venture capital
Judge Orders Icahn to Strike Confidential Information from Illumina Lawsuit
BioSpace
Wed, 01/17/24 - 09:36 am
Illumina
Grail
M&A
legal
Carl Icahn
Did Medtech M&A Come up Short in 2023?
Medical Devices and Diagnostics Industry
Mon, 01/15/24 - 09:49 am
Medtech
M&A
Amgen Emerges as Potential Cytokinetics Suitor as Novartis Pulls Away: Reports
BioSpace
Fri, 01/12/24 - 09:59 am
Novartis
Cytokinetics
Amgen
M&A
7 JPM Announcements You Don’t Want to Miss
MedCity News
Fri, 01/12/24 - 09:51 am
JPMHC 2024
Boston Scientfic
M&A
Axonics
Amazon
JNJ
Mayo Clinic
artificial intelligence
diabetes
Abbott Labs
Innovaccer
Merck
Alphabet spinout SandboxAQ buys Good Chemistry
Pharmaphorum
Fri, 01/12/24 - 09:43 am
SandboxAQ
Alphabet
drug discovery
M&A
Good Chemistry
Novartis drops pursuit of Cytokinetics - source
Reuters
Thu, 01/11/24 - 08:41 pm
Novartis
Cytokinetics
M&A
5 medtech trends to watch in 2024
Medtech Dive
Thu, 01/11/24 - 11:33 am
Medtech
M&A
pulsed field ablation
lab-developed tests
GSK Puts $1.4B on the Line in Aiolos Acquisition to Boost Asthma Pipeline
BioSpace
Tue, 01/9/24 - 09:50 am
GSK
Aiolos Bio
M&A
asthma
JPMHC 2024
Novartis in advanced talks to buy Cytokinetics
Reuters
Mon, 01/8/24 - 10:29 pm
Novartis
Cytokinetics
M&A
aficamten
Boston Scientific Bids on a Medtronic Foe
Medical Devices and Diagnostics Industry
Mon, 01/8/24 - 10:20 pm
Medtech
Axonics
Boston Scientific
M&A
urology
sacral neuromodulation
Merck inks $680M Harpoon buyout, spearing challenger to Amgen T-cell engager
Fierce Biotech
Mon, 01/8/24 - 11:36 am
Merck
Harpoon Therapeutics
M&A
T-cell engager
JPMHC 2024
J&J to acquire ADC drug developer Ambrx for $2B
BioPharma Dive
Mon, 01/8/24 - 11:35 am
JNJ
Ambrx
M&A
antibody-drug conjugate
JPMHC 2024
Novartis dances into JPM with $250M Calypso buyout, $185M RNAi alliance
Fierce Biotech
Mon, 01/8/24 - 11:33 am
Novartis
Calypso
M&A
RNAi
JPMHC 2024
All AbbVie's CEO wanted for Christmas was Cerevel—oh, and ImmunoGen, too
Fierce Biotech
Mon, 01/8/24 - 11:30 am
AbbVie
Richard Gonzalez
Cerevel Therapeutics
M&A
Stakes are high as biopharma gathers for JPM
Medical Marketing and Media
Sun, 01/7/24 - 04:18 pm
M&A
JPMHC 2024
Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference
Reuters
Fri, 01/5/24 - 11:25 am
M&A
JPMHC 2024
AbbVie
AstraZeneca
Bristol Myers Squibb
Carmot Therapeutics
Eli Lilly
Newly Launched Tome Biosciences Acquires Replace Therapeutics for $65M
BioSpace
Wed, 01/3/24 - 05:00 pm
Tome Biosciences
Replace Therapeutics
M&A
2 Biotechs That Could Get Bought Out in 2024
Yahoo/Motley Fool
Wed, 01/3/24 - 04:59 pm
M&A
BridgeBio Pharma
Cytokinetics
Inside AbbVie's $10B buyout of ImmunoGen—and the bidding war it swooped in on
Fierce Pharma
Tue, 01/2/24 - 10:11 pm
AbbVie
Immunogen
M&A
antibody-drug conjugate

Pages